Biolargo, Inc. revenue by segment BLGO

Annual Quarterly

Biolargo, Inc. splits its revenue into 2 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $5.8 million, 74% of the total.

USD in millions. The percent under a figure is the change from the year before.

FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Revenue
4
8
18
12
6
3
2
2
1
1
0
Product
2
-83.8%
share 47.9%
6
-65.6%
share 74.3%
17
+46.3%
share 94.3%
11
+158.5%
share 93.7%
4
+182.1%
share 75.4%
2
-13.9%
share 62.1%
2
share 75.0%
—
—
—
—
Services
2
+9.3%
share 52.1%
2
+96.5%
share 25.7%
1
+32.1%
share 5.7%
1
-46.9%
share 6.3%
1
+51.2%
share 24.6%
1
+58.0%
share 37.9%
1
share 25.0%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Chemicals & Allied Products (SIC 2800)
Listed as
BLGO (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westminster, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
880242
Former names
NUWAY MEDICAL INC (until Apr 3, 2007); NUWAY ENERGY INC (until Feb 5, 2003); LATIN AMERICAN CASINOS INC (until Feb 15, 2001)

Other Chemicals & Allied Products companies

All 20 Chemicals & Allied Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.